Pulmatrix Inc

Market cap: $7,377,981

Exchange: NAS

Sector: Health Technology

Share
Tweet

Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. on June 15, 2015 and is headquartered in Lexington, MA.

Key Statistics

Company Name

Pulmatrix Inc

Average Volume (10 days)

9,624

Average Volume (30 days)

19,463

Moving Average (50 days)

$1.86

Moving Average (200 days)

$1.88

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

7,377,981

Shares Outstanding

3,652,285

52-Week High Split Adjust Only

3.14

52-Week Low Split Adjust Only

1.55

Employee Count

35

Beta

0.1622

Next Earnings Date

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

-0.05%

Past 30 days

0.21%

Past 3 months

0.06%

Past 6 months

0.1%

Past year

-0.3%

Past 2 years

-0.64%

Past 5 years

-0.9%

Max % Change

-0.89%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Pulmatrix IncPULMn/an/a-2.5n/an/a
Peer AvgN/A1.650.95-5.11.651.38
Blueprint Medicines CorpBPMC6.593.81-13.86.595.53
Pieris Pharmaceuticals IncPIRSn/an/a-3.8n/an/a
Bio-Path Holdings IncBPTHn/an/a-3.0n/an/a